Therefore, we carried out a detailed characterization of CNA profiles: CNA mutation burden, the type of mutated genes, and association with mutator enzyme AID/RAG1/2 expression—to establish their correlation with prognosis in an adult B-ALL population treated with a standard intensive protocol according to PALG. This evidence concerns the gene AICDA and acute lymphoblastic leukemia.